title: Response to letter by Cheng.
authors: Department of Endocrinology, Clinica Sagrada Familia, Vilana 12, Barcelona 08022, Spain Rheumatology Unit, Hospital Universitari Vall Hebron, Barcelona, Spain.
authors: Guillem
authors: G
authors: Cuatrecasas
authors: Cayetano Alegre
authors: CA
authors: De Miguel
mesh_terms: D005260:Female; D005356:Fibromyalgia / Q000188:drug therapy*; D013006:Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D010146:Pain / Q000188:drug therapy*; D011788:Quality of Life
chemical_list: D013006:Growth Hormone
references: Kreitschmann-Andermahr I, Siegel S, Francis F, Buchfelder M, Schneider HJ, Kann PH, Wallaschofski H, Koltowska-Häggström M, Brabant G. Variation of the baseline characteristics and treatment parameters over time: an analysis of 15 years of growth hormone replacement in adults in the German KIMS database. Pituitary. 2012;15:72-80.
references: Webb SM, Strasburger CJ, Mo D, Hartman ML, Melmed S, Jung H, Blum WF, Attanasio AF. HypoCCS International Advisory Board. Changing patterns of the adult growth hormone deficiency diagnosis documented in a decade-long global surveillance database. J Clin Endocrinol Metab. 2009;94:392.